SynthesisInvestigational new drugs2018

Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis.

Akiyoshi Kasuga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.